As a neoadjuvant therapeutic regimen, IFN-α and 5-FU based chemoradiation has shown some promise in converting unresectable or borderline resectable patients to resectable status for locally advanced pancreatic cancer. This evidence concerns the gene IFNA1 and pancreatic neoplasm.